Cytiva, a life sciences company focused on the development and manufacture of therapeutics and a part of US-based Danaher Corporation, is expanding in the Greater Vancouver area of Canada. The company is relocating to a new 11,724m2 site in Burnaby that will produce aseptic filling machines.
The opening will increase the company’s machine production capacity by more than 200%. The site will act as a centre of excellence for Cytiva’s aseptic filling business, featuring R&D and service operations. It will also operate as a base for the company’s global customer user group.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The new facility is located near Vancouver International Airport, one hour from the US border.
General manager of aseptic filling Brent Lieffers commented: “Aseptic filling workcells are a first-to-market product. With this facility expansion, we can meet rapidly growing demand thanks to growing acceptance of what is a fundamentally different technology than what came before.”
Manufacturing is expected to begin at the new factory in September 2022. By the end of 2022, production will be fully transferred over and around 200 employees will work from the site. There will also be room for future expansion.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
